Search hospitals > California > Los Angeles
Mattel Children's Hospital - UCLA
Claim this profileLos Angeles, California 90095
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Brain Tumor
109 reported clinical trials
9 medical researchers
Summary
Mattel Children's Hospital - UCLA is a medical facility located in Los Angeles, California. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia, Brain Tumor and other specialties. Mattel Children's Hospital - UCLA is involved with conducting 109 clinical trials across 265 conditions. There are 9 research doctors associated with this hospital, such as Jacqueline N. Casillas, William A. May, Theodore Moore, MD, and Satiro De Oliveira, MD.Area of expertise
1Leukemia
Global LeaderNGS-MRD negative
Stage II
Stage I
2Tumors
Global LeaderStage I
Stage IV
Stage II
Top PIs
Jacqueline N. CasillasMiller Children's and Women's Hospital Long Beach6 years of reported clinical research
Expert in Tumors
Expert in Cancer
45 reported clinical trials
91 drugs studied
William A. MayMattel Children's Hospital UCLA6 years of reported clinical research
Expert in Tumors
Studies Brain Tumor
23 reported clinical trials
59 drugs studied
Theodore Moore, MDMattel Children's Hospital UCLA6 years of reported clinical research
Studies Tumors
Studies Germ Cell Tumors
21 reported clinical trials
59 drugs studied
Satiro De Oliveira, MDMattel Children's Hospital UCLA4 years of reported clinical research
Studies Lymphoma
Studies Tumors
17 reported clinical trials
54 drugs studied
Clinical Trials running at Mattel Children's Hospital - UCLA
Rhabdomyosarcoma
Osteosarcoma
Germ Cell Tumors
Brain Tumor
Leukemia
Ovarian Tumors
Non-Hodgkin's Lymphoma
Alveolar Rhabdomyosarcoma
Lymphoblastic Leukemia-Lymphoma
Acute Lymphoblastic Leukemia
Chemotherapy
for Rhabdomyosarcoma
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma. Another aim of the study it to find out how well patients with low risk rhabdomyosarcoma (LR-RMS) respond to standard chemotherapy when patients with VLR-RMS and patients who have rhabdomyosarcoma with DNA mutations get separate treatment. Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
Recruiting2 awards Phase 3
Combination Chemotherapy
for Rhabdomyosarcoma
This study is evaluating whether a combination of chemotherapy drugs is more effective than a single chemotherapy drug for treating rhabdomyosarcoma.
Recruiting2 awards Phase 35 criteria
Genetic Testing-Directed Therapy
for Pediatric Cancer
This study is evaluating whether genetic testing may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mattel Children's Hospital - UCLA?
Mattel Children's Hospital - UCLA is a medical facility located in Los Angeles, California. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia, Brain Tumor and other specialties. Mattel Children's Hospital - UCLA is involved with conducting 109 clinical trials across 265 conditions. There are 9 research doctors associated with this hospital, such as Jacqueline N. Casillas, William A. May, Theodore Moore, MD, and Satiro De Oliveira, MD.